Bivision Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, development, and commercialization of novel targeted radiopharmaceuticals to address significant unmet medical needs.
investor of
Metrics
marketPRIVATE
msh_idCOM:BIVISIONPHARMA
localeus
websitehttps://www.bivisionpharma.com
source_ref0c8505b3-43a0-4361-921f-4fd239ee00da
products_or_servicesNovel targeted radiopharmaceuticals, including JH02 (a Lutetium-177 labeled small molecule ligand targeting Prostate Specific Membrane Antigen for metastatic castration resistant prostate cancer treatment)
United States